Form 4 for AFRM Affirm Holdings, Inc.
Accepted 2025-07-09 00:00:00 ET · period of report 2025-07-07 · accession 0001628280-25-034687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-09 | 2025-07-07 | AFRM | Adkins Katherine | CLO | M - OptEx | $15.68 | +57.1K | 169.6K | +51% | +$895.4K |
| D | 2025-07-09 | 2025-07-07 | AFRM | Adkins Katherine | CLO | S - Sale+OE | $70.27 | -57.1K | 112.5K | -34% | -$4.01M |
| DM | 2025-07-09 | 2025-07-07 | AFRM | Adkins Katherine | CLO | M - OptEx | $0.00 | -57.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-07-07 | M | A | 28,000 | $8.80 | 140,467 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. |
| 2 | Common | Class A Common Stock | 2025-07-07 | M | A | 29,102 | $22.30 | 169,569 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. |
| 3 | Common | Class A Common Stock | 2025-07-07 | S | D | 57,102 | $70.27 | 112,467 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. (F2) Represents the weighted average sale price of the shares sold from $70.00 to $70.62 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-07-07 | M | D | 29,102 | $0.00 | 53,748 | D | $22.30 · — to 2032-09-16 | 29,102 Class A Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. (F4) The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-07-07 | M | D | 28,000 | $0.00 | 0 | D | $8.80 · — to 2029-10-14 | 28,000 Class A Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2024. (F3) The stock option vested as to 25% of the underlying shares on September 14, 2020, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. |